23Andme Holding Co. (ME)

Jan 17, 2025, 2:13 PM EST - 8 hours ago

23andMe has been quietly exploring a possible sale of its telehealth business, Lemonaid

Jan 8, 2025, 7:30 AM EST - 9 days ago

23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit's Trusted Technology

Dec 24, 2024, 8:00 AM EST - 24 days ago

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

DOCS DXCM GDRX HIMS OSCR PGNY TDOC

Nov 20, 2024, 7:30 AM EST - 2 months ago

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador's Precision Medicines for Immunology & Inflammation

Nov 12, 2024, 6:56 PM EST - 2 months ago

23andMe Holding Co. (ME) Q2 2025 Earnings Call Transcript

Nov 12, 2024, 5:51 PM EST - 2 months ago

23andMe cuts 40% of staff in restructuring

Nov 12, 2024, 5:01 PM EST - 2 months ago

What's happening with 23andMe? Mass layoffs and restructuring are the latest blow for the embattled DNA testing company

Nov 12, 2024, 12:52 PM EST - 2 months ago

23andMe reports sales decline day after announcing plans to cut 40% of workforce

Nov 12, 2024, 11:01 AM EST - 2 months ago

Genetic testing firm 23andMe cuts 40% of its workforce amid financial struggles

Nov 12, 2024, 8:05 AM EST - 2 months ago

23andMe's stock turns lower after company posts its latest quarterly loss

Nov 11, 2024, 10:20 PM EST - 2 months ago

23andMe Lays Off 40% of Staff, Shuts Drug Development Business

Nov 11, 2024, 7:40 PM EST - 2 months ago

23andMe to slash 40% of its workforce, end therapeutics program to cut costs

Nov 11, 2024, 5:42 PM EST - 2 months ago

23andMe cuts 40% of its workforce

Nov 11, 2024, 5:30 PM EST - 2 months ago

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

Nov 7, 2024, 5:54 PM EST - 2 months ago

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

Nov 7, 2024, 7:30 AM EST - 2 months ago

23andMe to Report Q2 FY2025 Financial Results

Oct 30, 2024, 5:00 PM EDT - 2 months ago

23andMe Regains Compliance With Nasdaq Listing Requirements

Oct 30, 2024, 4:52 PM EDT - 2 months ago

23andMe appoints new board members as it works to stem the company's slide

Oct 29, 2024, 11:54 AM EDT - 2 months ago

23andMe appoints three new board members following abrupt resignations

Oct 29, 2024, 7:30 AM EDT - 2 months ago

23andMe Appoints Three New Independent Directors to Board

Oct 28, 2024, 5:14 AM EDT - 2 months ago

DNA & RNA Banking Services Market Report 2024-2030, Featuring EasyDNA, DNA Genotek, 23andMe, GoodCell, ProteoGenex, Infinity Biologix, deCODE genetics, LGC Biosearch Technologies & PreventionGenetics

Oct 23, 2024, 8:30 AM EDT - 3 months ago

Inside the fall of 23andMe

Oct 16, 2024, 8:15 AM EDT - 3 months ago

23andMe Announces Completion of 1-for-20 Reverse Stock Split

Oct 11, 2024, 8:15 AM EDT - 3 months ago

23andMe Announces 1-for-20 Reverse Stock Split

Oct 1, 2024, 6:52 AM EDT - 3 months ago

ME INVESTOR NOTICE: Current 23andMe Holding Co. Shareholders are Notified to Contact BFA Law about Investigation into the Board of Directors (Nasdaq:ME)

Sep 30, 2024, 6:11 PM EDT - 3 months ago

23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows

Sep 29, 2024, 6:40 AM EDT - 3 months ago

ME INVESTOR UPDATE: Shareholders of 23andMe Holding Co. are Alerted of Pending Investigation into the Company; Contact BFA Law if You Own Substantial Shares (Nasdaq:ME)

Sep 27, 2024, 3:33 PM EDT - 4 months ago

ME INVESTIGATION UPDATE: 23andMe Holding Co. Shareholders are Encouraged to Contact BFA Law about the Potential Lawsuit against the Company

Sep 27, 2024, 6:16 AM EDT - 4 months ago

ME INVESTIGATION NOTICE: The Investigation into 23andMe Holding Co. is Ongoing – Contact BFA Law if You are a Current Shareholder (Nasdaq:ME)

Sep 26, 2024, 8:34 AM EDT - 4 months ago

ME INVESTOR UPDATE: BFA Law Alerts 23andMe Holding Co. Shareholders to Contact the Firm about its Investigation into the Company's Board of Directors (Nasdaq:ME)

Sep 25, 2024, 7:30 AM EDT - 4 months ago

23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating

Sep 25, 2024, 7:11 AM EDT - 4 months ago

ME SHAREHOLDER UPDATE: 23andMe Holding Co. is Under Investigation for Breaches of Fiduciary Duties; Current Shareholders are Urged to Contact BFA Law (Nasdaq:ME)

Sep 24, 2024, 3:36 PM EDT - 4 months ago

ME SHAREHOLDER NEWS: Current 23andMe Holding Co. Shareholders are Encouraged to Contact BFA Law about Investigation into the Company for Breaches of Fiduciary Duties

Sep 24, 2024, 9:30 AM EDT - 4 months ago

Barrack, Rodos & Bacine Is Investigating 23andMe Holding Co.

Sep 23, 2024, 6:18 AM EDT - 4 months ago

ME INVESTIGATION NOTICE: 23andMe Holding Co.'s Board of Directors is Being Investigated; Current Shareholders are Urged to Contact BFA Law (Nasdaq:ME)

Sep 21, 2024, 7:13 AM EDT - 4 months ago

ME INVESTOR UPDATE: 23andMe Shareholders are Notified to Contact BFA Law about Ongoing Investigation into the Company for Breaches of Fiduciary Duties (Nasdaq:ME)

Sep 20, 2024, 4:46 AM EDT - 4 months ago

23andMe directors resign as the CEO of the genetic-testing company seeks to take it private

Sep 19, 2024, 3:33 PM EDT - 4 months ago

ME STOCK NOTICE: An Investigation has been Initiated Against 23andMe Holding Co. for Breaches of Fiduciary Duties – Shareholders are Urged to Contact BFA Law

Sep 19, 2024, 2:40 PM EDT - 4 months ago

23andMe faces Nasdaq delisting after its entire board resigns

Sep 19, 2024, 12:48 PM EDT - 4 months ago

23andMe faces Nasdaq delisting

Sep 19, 2024, 11:25 AM EDT - 4 months ago

Wolf Popper LLP is Investigating Whether the Offer to Acquire 23andMe Holding Co. By Its Controlling Shareholder Is Fair to the Minority Shareholders

Sep 19, 2024, 10:43 AM EDT - 4 months ago

How 23andMe Went From Market Darling to Losing Its Entire Board

Sep 18, 2024, 1:48 PM EDT - 4 months ago

All 23andMe board members but CEO resign over no adequate buyout offers

Sep 18, 2024, 12:54 PM EDT - 4 months ago

23andMe board resigns in feud over CEO Anne Wojcicki's plan to take company private

Sep 18, 2024, 7:06 AM EDT - 4 months ago

23andMe's stock tumbles 7% after independent directors quit in clash with CEO over buyout plan

Sep 18, 2024, 1:46 AM EDT - 4 months ago

23andMe sees independent board directors quit en masse